|
HS Code |
727143 |
| Chemical Name | Cis-2,6-Dimethylpiperidine |
| Molecular Formula | C7H17N |
| Molar Mass | 115.22 g/mol |
| Cas Number | 6384-23-2 |
| Appearance | Colorless to pale yellow liquid |
| Boiling Point | 157-160 °C |
| Density | 0.85 g/cm³ (approximate) |
| Refractive Index | 1.435 (at 20°C) |
| Purity | Typically ≥98% |
| Smiles | CC1CCCC(C)N1 |
| Flash Point | 41 °C |
| Isomerism | Cis isomer of 2,6-dimethylpiperidine |
As an accredited Cis-2,6-Dimethylpiperidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 100 grams of Cis-2,6-Dimethylpiperidine, sealed with a screw cap and hazard labeling. |
| Shipping | Cis-2,6-Dimethylpiperidine is shipped in tightly sealed, chemical-resistant containers, typically under ambient temperature. Due to its flammability and possible health hazards, it complies with relevant regulatory guidelines (e.g., DOT, IATA) and is labeled accordingly. Containers are securely packaged to prevent leaks, with safety data sheets included for safe handling and emergency response. |
| Storage | Cis-2,6-Dimethylpiperidine should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizers and acids. Protect it from moisture and direct sunlight. Store under an inert atmosphere, such as nitrogen, if recommended. Ensure proper chemical labeling, and keep it in a dedicated chemical storage cabinet or flammable liquids cabinet if applicable. |
Applications of Cis-2,6-Dimethylpiperidine in Industrial ManufacturingCis-2,6-Dimethylpiperidine serves as a high-purity intermediate in several specialized chemical production sectors. Our facility supports B2B partners with material backed by strict batch traceability, technical support for process scale-up, and consistent analytical characterization. Below are core industrial routes where this compound delivers value, with detailed compliance, formulation practice, and end-market output. 1. Pharmaceutical API Synthesis (Active Pharmaceutical Ingredient Manufacturing)This compound acts as a critical nitrogen-containing building block for the synthesis of certain antihypertensive and antiviral APIs. Its steric profile facilitates selective hydrogenation steps and chiral amine introduction in multi-step organic synthesis. Contract manufacturing organizations and originator pharmaceutical companies specify this intermediate in their GMP supply chains for scalable routes to target molecules. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient IntermediateCis-2,6-Dimethylpiperidine enables agrochemical manufacturers to build highly substituted heterocyclic platforms, specifically in the segment of fungicides and insecticides. The compound’s steric constraint benefits the selective synthesis of biologically active molecules, and its controlled reactivity fits standard process safety and impurity control protocols established in major crop-protection production sites. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Catalyst Ligand Modification in Fine Chemical ProductionCis-2,6-Dimethylpiperidine functions in specialty catalyst manufacturing, where its unique profile allows fine adjustment of electronic and steric properties for homogeneous and heterogeneous catalyst systems. Large-scale producers of ligands and catalyst supports use this material to prepare transition metal complexing agents for petrochemical, polymerization, and pharmaceutical manufacturing lines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Performance Polymer Monomer SynthesisChemical companies incorporate cis-2,6-dimethylpiperidine in the synthesis of specific monomers for performance polymers, especially where ring-alkylated structures enhance thermal, chemical, and mechanical properties. The compound’s high reactivity enables it to participate in controlled polymer growth, offering downstream formulators monomers with desired branching and cross-linking features. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Specialty Fine Chemical Intermediates for Flavors and FragrancesThe compound’s controlled steric hindrance and nitrogen functionality facilitate the synthesis of fragrance bases and flavoring agents in the specialty fine chemical sector. Manufacturers deploy it for creating high-purity intermediates necessary in the assembly of unique piperidinyl and alkylamine profiles, essential for differentiating signature aromas and taste products. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Cis-2,6-Dimethylpiperidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Day in, day out, chemical plants worldwide rely on solid, reliable intermediates to drive their process chemistry forward. Every operator on our floor knows how a wrong isomer can derail weeks of effort or send yields tumbling. Cis-2,6-Dimethylpiperidine stands out on our roster. This molecule, tailored at the stereochemical level, serves customers who can’t compromise on precision—synthetic chemists, pharmaceutical innovators, and agrochemical formulators keeping their focus sharp on performance and purity.
We prepare this product on-site through carefully controlled hydrogenation and resolution sequences. Unlike its trans isomer or the racemic blend, the cis configuration offers a unique three-dimensional scaffold, which often acts as a decisive building block for downstream active compounds. The purity levels reach well above industry expectations, as even small impurities in the isomeric content can cause lost time and extra purification steps, not to mention regulatory headaches when producing regulated end-products.
Operators on our team don’t just glance at batch numbers—they monitor key physical data, downstream utility, and stability over time. We typically supply cis-2,6-dimethylpiperidine in sealed drums with controlled headspace, with product specifications confirmed on every lot. The melting point runs within a tight range, and GC analysis ensures the cis-to-trans ratio stays right where synthetic chemists need it. Handling procedures are built from years of real-world feedback, so lab techs find our material easy to transfer, store, and weigh out. Anhydrous packaging prevents moisture pickup, which can sap potency or drive hydrolysis if left unchecked.
Feedback from our long-term customers highlights reduced rework and minimized batch failures once using our product. We track downstream complaints as closely as initial process yields, and routinely investigate any deviation by pulling reference samples and repeating analysis. Our warehouse teams learned early to sticker and store this compound well away from oxidizers and acids—a simple discipline that keeps both the material and its handlers safe.
Anyone who’s worked in synthetic intermediates knows how isomer selectivity shapes every stage. A trans contaminant can turn a multistep synthesis into a dead end. Pharmaceutical teams across Europe and Asia once reported stumbling blocks in making advanced heterocycles when their supply chain delivered only racemic or trans material. Their data made it clear: the cis isomer fits biological and catalytic targets in ways the alternatives cannot.
Take ligand and catalyst production for complex coupling reactions. Teams running production-scale batches of chiral ligands said our cis-2,6-dimethylpiperidine shortened their purification workflow. Switching from the cis to the mixed isomer blend led to variable selectivity—and more time reworking off-spec material. Medical chemistry groups report improved yields and easier downstream modifications since they switched to our consistently supplied cis product.
While many intermediates gain attention through cost or volume, the added value of a precise isomer rarely shows up on spread sheets. It emerges in improved timelines, fewer failed syntheses, and safer scale-up ventures. Early in our manufacturing experience with this compound, an agricultural synthesis partner flagged a 17% drop in main product yield after trialing a cheaper, off-shore isomer sample. Process data pointed back to the isomeric configuration. We worked with partners to refit purification steps, then standardized our analytical workflow to guarantee cis content every time.
After correcting these stumbling blocks, downstream facilities saw process stability climb steeply. Formulation chemists could now predict and repeat their modifications with confidence, laying out R&D timelines without factoring in extra purification or analytical confirmation for every shipment.
Both the cis and trans isomers of 2,6-dimethylpiperidine build upon a six-membered ring, but the placement of hydrogen atoms and methyl groups changes the entire reactivity profile. We’ve put side-by-side product through cross-coupling trials and catalytic conversions in our pilot plant. The cis isomer creates fewer byproducts, giving chemists material that flows directly into scale-up. Customer feedback supports these findings, highlighting greater reliability in hydrogenation steps and less hassle during separation.
Trans isomer batches often behave stubbornly in hydrogen bond-rich environments or under asymmetric catalytic conditions. Lab notebooks from process development teams show trans often creates branching reactions or sluggish conversions, leading to poor conversion efficiency. Researchers rely on the cis form when their process or active molecule incorporates sensitive ring geometries, sterically-controlled ligands, or optically active pharmaceutical cores. For pilot and commercial scale, this distinction shortens development cycles and pushes timelines forward.
We’ve seen the reach of cis-2,6-dimethylpiperidine into pharmaceuticals, specialty polymers, battery materials, and advanced catalysts. Medicinal chemistry programs regularly list the product as a key backbone for constructing alkaloid analogues and chiral auxiliaries. In electronic materials, our customers implement the cis version as a ring scaffold for stabilizing high-value polymers. Everyone from process R&D teams to kilo lab technicians notice the reliability of batch-to-batch quality, with little need for supplemental purification.
As scale changes, our clients often face evolving demands on purity and supply. Our early investments in continuous production lines and chromatography set-ups paid off—allowing us to guarantee timely deliveries, even during surges in regulatory demand for pharmaceutical or agricultural projects. Where other suppliers substitute generic blends, we send every drum backed by traceable quality records and full product analytics, sparing researchers unwanted surprises.
We learned early that small shortcuts in the plant create ripples across the supply chain. One batch knowingly cut corners—by skipping a drying stage—showed hydrolytic breakdown within two weeks, rendering a tenth of the shipment useless. Since then, our QC program expanded to cover water activity, headspace oxygen, and shelf-life stability, not just isomeric ratio or assay. Customers who run demanding reactions, from metal-catalyzed couplings to protecting-group manipulations, depend on these measures for their workflow.
In conversation with partner sites, feedback shaped our final product offering. Some labs wanted higher concentration standards for blend-ready integration, while others pressed for ultra-low solvent content or single-digit ppm moisture specifications. We designed flexible, modular packaging and storage approaches—a simple solution developed from operator input, not just managerial edict. Ongoing dialogue with chemists and supervisors continues to hone our process from the loading dock to the dispatch bay.
With regulatory oversight climbing in every market, detailed sourcing reports now common in downstream compliance reviews. Rather than hide behind a distributor chain, we provide one-step-to-origin traceability, mapping every raw material and process stage throughout the batch’s journey. This transparency means each drum of cis-2,6-dimethylpiperidine comes with digital documentation tracing origin, analytical findings, and QA/QC signatures.
This extends beyond the technical, affecting trust and accountability in every supply relationship. Most buyers confronted with ambiguous sourcing look for new partners. By offering complete transparency, we see regular return orders from multinationals and small-batch specialist firms alike, who value traceability over mystery. The added record-keeping effort on our end protects their projects from unforeseen regulatory or IP conflicts further down the road.
Our technical service line once existed as a support tool for larger volume clients, but grew into a hub for day-to-day collaboration with lab teams facing new synthesis challenges. One customer approached us about batch inconsistency, showing NMR traces with unexpected peaks. Drawing on archived batch records, our team identified a subtle shift in hydrogenation pressure as the culprit—something only direct manufacturer access could uncover. We corrected the process, documented the fix, and sent out verified replacement lots at our cost.
Today, we encourage open reporting of even minor anomalies or off-odors at the receiving end. Our staff tracks every inquiry, comparing reported data with standard reference samples. Internal workshops now cover practical troubleshooting, blending shift supervisor experience with input from medicinal and process chemists who rely on our product for new synthetic routes. These direct channels mean reformulations or process interruptions rarely hold up production for long.
Every operator on our line completes detailed safety protocol training before handling cis-2,6-dimethylpiperidine. Having fielded calls from facilities unsure about storage or spill response, we developed simple, clear information resources—not just dense MSDS sheets. Our safety data derives directly from plant observations and documented incidents handled by production leads, not just abstract literature.
Requests for detailed impurity profiles, purity declarations, or environmental impact data are routine. We maintain a repository of each certificate and analysis, sending digital copies for regulatory audits and customer records. Regulatory protocols for pharmaceuticals, agrochemicals, and other high-scrutiny sectors keep us focused on continuous improvement. Our compliance team maintains an open line to customer regulatory officers, taking on the complexity that gives customers peace of mind.
Ongoing investment in plant modernization, digital documentation, and analytical equipment reflects our direct commitment to quality. Addressing plant-floor problems head-on, not in distant board rooms, helps us find solutions that work across all scales. Engineers and operators maintain line-of-sight from raw material intake through product shipment, ensuring that every drum reflects a unified team’s hard work and experience.
Cis-2,6-dimethylpiperidine, once a specialty offering, has grown into a foundational intermediate, supporting the critical work of scientists and manufacturers worldwide. Its clear, reliable benefits in synthetic versatility, purity, and process safety make it not just another chemical, but a cornerstone of effective industrial and laboratory practice. By drawing on field knowledge and always responding to the newest demands in chemistry, we keep improving—growing in response to the evolving needs of the industry and the high standards set by those who depend on us.